Estrella Immunopharma, Inc. Share Price
ESLAEstrella Immunopharma, Inc. Stock Performance
Open $0.96 | Prev. Close $0.98 | Circuit Range N/A |
Day Range $0.96 - $0.96 | Year Range $0.78 - $3.08 | Volume 351 |
Average Traded $0.96 |
Estrella Immunopharma, Inc. Share Price Chart
About Estrella Immunopharma, Inc.
Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidate is EB103, which is in clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It has a collaborative agreement with Eureka and Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California.
Estrella Immunopharma, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
01-Jul-26 | $0.95 | $0.96 | +0.00% |
01-Jul-26 | $0.95 | $0.96 | -2.03% |
30-Jun-26 | $1.06 | $0.98 | +3.14% |
25-Jun-26 | $0.95 | $0.95 | -2.55% |
23-Jun-26 | $0.98 | $0.98 | -11.71% |
09-Jun-26 | $1.12 | $1.11 | +3.74% |
03-Jun-26 | $1.07 | $1.07 | -4.04% |
FAQs on Estrella Immunopharma, Inc. Share Price
Can I buy Estrella Immunopharma, Inc. shares in India?
What is the share price of Estrella Immunopharma, Inc.?
What is the 5 year returns of Estrella Immunopharma, Inc.?
What are the high & low stock price of Estrella Immunopharma, Inc. today?
What is the 52-week high and low of Estrella Immunopharma, Inc. stock?